Scilex Holding (SCLX) Assets Average (2021 - 2026)

Scilex Holding (SCLX) posted quarterly Assets Average of $329.3 million for Q1 2026, up 283.07% year-over-year from $86.0 million in Q1 2025, and up 2.77% on a QoQ basis from $320.4 million in Q4 2025.

Scilex Holding (SCLX) Assets Average (2021 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Assets Average for 6 consecutive years, with $329.3 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Assets Average rose 283.07% year-over-year to $329.3 million; the TTM figure through Mar 2026 stood at $329.3 million (up 283.07% YoY), while the FY2025 annual figure was $229.0 million, up 135.73% from the prior year.
  • Assets Average came in at $329.3 million for Q1 2026 at Scilex Holding, up from $320.4 million in the prior quarter.
  • The five-year high for Assets Average was $329.3 million in Q1 2026, with the low at $81.4 million in Q2 2025.
  • Average Assets Average over 5 years is $132.0 million, with a median of $102.5 million recorded in 2024.
  • Across the five-year window, Assets Average slipped 24.98% in 2023 and jumped 283.07% in 2026, its largest moves.
  • Year by year, Assets Average stood at $94.0 million in 2022, then slipped by 3.27% to $90.9 million in 2023, then advanced by 6.35% to $96.7 million in 2024, then surged by 231.39% to $320.4 million in 2025, then gained by 2.77% to $329.3 million in 2026.
  • According to Business Quant data, Assets Average over the past three periods registered $329.3 million, $320.4 million, and $179.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 114.53 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 200.05 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 135.21 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 114.04 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 132.78 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 91.55 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 57.65 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 208.08 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn 329.31 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 329.31 Mn
Dec 31, 2025 320.43 Mn
Sep 30, 2025 179.82 Mn
Jun 30, 2025 81.37 Mn
Mar 31, 2025 85.96 Mn
Dec 31, 2024 96.69 Mn
Sep 30, 2024 102.49 Mn
Jun 30, 2024 97.89 Mn
Mar 31, 2024 96.27 Mn
Dec 31, 2023 90.92 Mn
Sep 30, 2023 103.50 Mn
Jun 30, 2023 106.26 Mn
Mar 31, 2023 86.29 Mn
Dec 31, 2022 93.99 Mn
Sep 30, 2022 121.88 Mn
Jun 30, 2022 141.64 Mn
Mar 31, 2022 109.45 Mn
Dec 31, 2021 108.79 Mn
Sep 30, 2021 139.77 Mn
Jun 30, 2021 139.98 Mn